Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Epilepsia Open
|
September 9, 2022
Effectiveness of perampanel as the only add-on: Retrospective, multicenter, observational real-life study on epilepsy patients
Sara Gasparini, Edoardo Ferlazzo, Sabrina Neri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 17, 2024
Retrospective analysis of a tertiary care centre of sex differences in risk factors, aetiology and short-term clinical outcome after revascularization treatment in young adults' ischemic stroke
Rosaria Renna, Gionata Spagnoletti, Mariana Rippa, et al.
Journal of the Neurological Sciences
|
November 17, 2023
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
Angelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of Neurology
|
June 7, 2025
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study
Angelo Pascarella, Marilisa Pasquale, Domenico Abelardo, et al.
Journal of the Neurological Sciences
|
June 26, 2024
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
Angelo Pascarella, Lucia Manzo, Sara Gasparini, et al.
Neurology and Therapy
|
November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy
Roberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia
|
December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study
Roberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology
|
February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy
Emanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Seizure
|
February 9, 2021
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy
Niccolò Orlandi, Emanuele Bartolini, Daniela Audenino, et al.
Seizure
|
April 27, 2023
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience
Niccolò Orlandi, Giuseppe d'Orsi, Giada Pauletto, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Epilepsia Open
|
September 9, 2022
Effectiveness of perampanel as the only add-on: Retrospective, multicenter, observational real-life study on epilepsy patients
Sara Gasparini, Edoardo Ferlazzo, Sabrina Neri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 17, 2024
Retrospective analysis of a tertiary care centre of sex differences in risk factors, aetiology and short-term clinical outcome after revascularization treatment in young adults' ischemic stroke
Rosaria Renna, Gionata Spagnoletti, Mariana Rippa, et al.
Journal of the Neurological Sciences
|
November 17, 2023
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
Angelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of Neurology
|
June 7, 2025
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study
Angelo Pascarella, Marilisa Pasquale, Domenico Abelardo, et al.
Journal of the Neurological Sciences
|
June 26, 2024
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
Angelo Pascarella, Lucia Manzo, Sara Gasparini, et al.
Neurology and Therapy
|
November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy
Roberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia
|
December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study
Roberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology
|
February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy
Emanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Seizure
|
February 9, 2021
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy
Niccolò Orlandi, Emanuele Bartolini, Daniela Audenino, et al.
Seizure
|
April 27, 2023
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience
Niccolò Orlandi, Giuseppe d'Orsi, Giada Pauletto, et al.
Page
of 4